Iovance Biotherapeutics
ISIN US4622601007
|WKN A2DT49
Overview
Description
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 3,017.98 m |
| EPS, EUR | -1.75 |
| P/B ratio | 5.10 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 1.10 m |
| Net income, EUR | -410.73 m |
| Profit margin | -37,345.42% |
What ETF is Iovance Biotherapeutics in?
There are 22 ETFs which contain Iovance Biotherapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Iovance Biotherapeutics is the WisdomTree BioRevolution UCITS ETF USD Acc.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| WisdomTree Megatrends UCITS ETF USD | 0.21% | Equity World Social/Environmental Innovation | 582 | 0.50% | 9 | - | A3EYCN | IE0000902GT6 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.07% | Equity United States Small Cap | 1,431 | 0.14% | 30 | +23.70% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,989 | 0.28% | 7 | +18.14% | A2DWAC | IE00BDGV0746 |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0.40% | Equity World Health Care Social/Environmental Innovation | 95 | 0.30% | 3 | -1.84% | DBX0R2 | IE000KD0BZ68 |
| SPDR MSCI ACWI IMI UCITS ETF | 0.00% | Equity World | 3,518 | 0.17% | 1,268 | +23.93% | A1JJTD | IE00B3YLTY66 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,989 | 0.25% | 71 | +26.52% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,417 | 0.45% | 742 | +16.21% | A1W56P | IE00BCBJG560 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 5,853 | 0.24% | 266 | +25.17% | A2QL8V | IE00BNG8L385 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 3.86% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 2 | -5.23% | A3CY21 | IE000O8KMPM1 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.16% | Equity United States Small Cap | 1,486 | 0.30% | 927 | +20.49% | A1XEJT | IE00BJZ2DD79 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.07% | Equity United States Small Cap | 1,431 | 0.14% | 117 | +22.43% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.01% | Equity United States Multi-Factor Strategy | 1,989 | 0.25% | 32 | +26.17% | A2DND0 | IE00BDGV0308 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,989 | 0.28% | 23 | +15.34% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.02% | Equity United States Small Cap | 1,639 | 0.43% | 1,479 | +19.66% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.42% | Equity United States Health Care Biotech | 222 | 0.35% | 31 | +2.62% | A2JDYM | IE00BDZVHG35 |
| iShares MSCI World Small Cap UCITS ETF | 0.05% | Equity World Small Cap | 3,376 | 0.35% | 3,462 | +15.71% | A2DWBY | IE00BF4RFH31 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.42% | Equity United States Health Care Biotech | 222 | 0.35% | 412 | +3.15% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.03% | Equity United States Small Cap | 1,752 | 0.30% | 443 | +25.93% | A12HU5 | IE00BSPLC413 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 1,563 | 0.12% | 17 | +32.00% | A3DJRF | IE000L2ZNB07 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity North America Social/Environmental | 1,563 | 0.12% | 107 | +32.54% | A3DJRE | IE000O58J820 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity World Social/Environmental | 5,853 | 0.24% | 319 | +25.23% | A2QL8U | IE00BNG8L278 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.15% | Equity United States Small Cap | 1,795 | 0.30% | 2,510 | +20.43% | A1XFN1 | IE00BJ38QD84 |
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.